Trials / Completed
CompletedNCT02173262
REaCT Integrated Consent Model to Compare Two Standard of Care Regimens
Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for Primary Prophylaxis of Taxotere/Cyclophosphamide-Induces Febrile Neutropenia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- Ottawa Hospital Research Institute · Academic / Other
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The Integrated Consent Model is being increasingly used internationally to improve patient care. In this feasibility study we will explore whether the model is feasible in practice; and whether it can be used to increase the number of physicians and patients who take part in clinical trials, and address the critical issue around the optimal febrile neutropenia prevention by randomizing eligible patients to either G-CSF or ciprofloxacin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | G-CSF | |
| DRUG | Ciprofloxacin |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2014-06-24
- Last updated
- 2017-11-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02173262. Inclusion in this directory is not an endorsement.